Found 1240 Results
Page 37 of 248
Page 37 of 248
Page 37 of 248
Development of N=1 RNA Therapies in the Netherlands and Europe
After the development of Milasen in the United States, there has been an increase in the development of antisense oligonucleotide therapies for patients with unique mutations.
November 3, 2021
Page 37 of 248
